Created by the White House Office of Science and Technology Policy, the Pandemic Innovation Task Force will develop vaccines, treatments, diagnostic testing and other tools, officials close to the matter said, as reported by Bloomberg. Cecilia Rouse, PhD, chair of the Council of Economic Advisers, said in a Jan. 12 meeting that the group will also focus on managing the “endemic phase.”
The group won’t focus on daily pandemic responses or the omicron variant. Instead, it will prepare projects aimed to help manage new variants that could emerge within six months to two years. By building and exercising new capabilities, the U.S. will bolster its long-term biodefenses, officials said.
The task force is led by Eric Lander, PhD, science adviser for President Joe Biden, and Dawn O’Connell, assistant secretary for preparedness at HHS.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
